Population Dynamics of MafA-Positive Cells During Ontogeny of Human Pancreas by Kaligin M. et al.
BioNanoScience 2017 vol.7 N2, pages 352-359
Population Dynamics of MafA-Positive Cells During
Ontogeny of Human Pancreas
Kaligin M., Pliushkina A., Titova A., Titova M., Gumerova A., Kiassov A.
Kazan Federal University, 420008, Kremlevskaya 18, Kazan, Russia
Abstract
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cell differentiation are often chosen as markers of β cell progenitors. One of these transcription
factors is MafA, which according to data in literature activates the expression of insulin gene in
β cells. Other data support the hypothesis that MafA is required solely for the regulation of
insulin secretion by β cells of adult islets and is not involved in the development of islet cells. In
this paper, we study the role of MafA through both examination of human pancreas ontogeny
and comparison of these data with dynamic changes in the population of insulin-positive and
glucagon-positive cells. The aim of this research was the immunohistochemical analysis of MafA,
insulin,  and  glucagon  expression  during  human  pancreas  ontogeny.  The  research  was
conducted on whole embryos and isolated human fetal organs, obtained as a result of either
miscarriage or legal medical abortion with voluntary consent of patients, and also on autopsy
material from infant and adult human pancreas. As a result of this study, it was found that,
during the ontogeny of human pancreas, the first MafA-positive cells appear in the islets at
12.5 weeks of gestation, that is, later than both insulin-positive cells (11.5 weeks of gestation)
and glucagon-positive cells (8.5 weeks of gestation). No MafA-positive cells were found in the
epithelium of pancreatic ducts. The number of MafA-positive cells in the islets increases during
pancreatic organogenesis. The results of our research do not allow us to regard MafA as a
marker of undifferentiated progenitors of islet cells. Based on this, we believe that the results
obtained in this study are a supplementary contribution to the hypothesis that relates MafA to
the markers of adult β cells.
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